EFTA00597664Set 9
14p5,962w
also other miscellaneous DREs that arise primarily
through the combined use of one DRE. For example, a partnership between a taxpayer and a
DRE that is wholly-owned ... does not constitute a partnership for federal tax
purposes; rather, the partnership is a DRE, absent an election (under the check-the-box
regulations discussed below) to be treated ... rules, there are conflicting views regarding the treatment of a grantor
trust as a DRE. While the plain language of the Code's grantor trust rules appears to imply that
https://www.justice.gov/epstein/files/DataSet%209/EFTA00597664.pdf
EFTA01217687Set 9
2013-07-1516p2,521w
Participants: ( ), Self ( jeevacation )
Skype
2013-07-24 19:02:48 UTC 2
Sender: Nice Dre (
Participants: Nice Dre ( ), Self ( jeevacation )
added jeevacation to this conversation
Skype ... Sender: Nice Dre (
Participants: Nice Dre ( ), Self (jeevacation )
added jeevacation to this conversation
Skype
2013-08-19 22:45:14 (UTC 1
Sender: Lawrence Krauss (
Participants: Lawrence Krauss ( ), Self (jeevacation
https://www.justice.gov/epstein/files/DataSet%209/EFTA01217687.pdf
EFTA01075338Set 9
2013-05-2140p19,322w
entity is a corporation, a partnership, a sole proprietorship,
branch or disregarded entity (DRE) for federal tax purposes.48 The regulations eliminated a
multi-factor test in determining the proper classification ... under the
relevant tax laws of a foreign country and as a branch (i.e., DRE) of a CFC that is its sole owner
for U.S. tax purposes.s49 The Notice stated
https://www.justice.gov/epstein/files/DataSet%209/EFTA01075338.pdf
EFTA00582641Set 9
2016-07-238p1,955w
assay should not be the only test used for diagnostic purposes.
Additional evaluation using DRE, ultrasound, T R or similar procedures may
be used for this purpose. Predictions of disease ... FREE PSA RISK ASSESSMENT
The probability of prostate cancer for men with non -suspicious DRE results, by
age group, using PSA values between 4.000 and 10.00e ng/mt and percent
https://www.justice.gov/epstein/files/DataSet%209/EFTA00582641.pdf
EFTA00594095Set 9
2015-10-295p1,487w
assay should not be the only test used for diagnostic purposes.
Additional evaluation using DRE, ultrasound, TUR or similar procedures may
be used for this purpose. Predictions of disease recurrence ... FREE PSA RISK ASSESSMENT
The probability of prostate cancer for men with non-suspicious DRE results, by
age group, using PSA values between 4.000 and 10.000 ng/mL and percent FREE
https://www.justice.gov/epstein/files/DataSet%209/EFTA00594095.pdf
EFTA00282981Set 9
2016-07-238p1,909w
assay should not be the only test used for diagnostic purposes.
Additional evaluation using DRE, ultrasound, TUR or similar procedures may
be used for this purpose. Predictions of disease recurrence ... FREE PSA RISK ASSESSMENT
The probability of prostate cancer for men with non -suspicious DRE results, by
age group, using PSA values between 4.000 and 10.000 ng/ml. and percent FREE
https://www.justice.gov/epstein/files/DataSet%209/EFTA00282981.pdf
EFTA01100382Set 9
2015-10-295p1,385w
assay should not be the only test used for diagnostic purposes.
Additional evaluation using DRE, ultrasound, TUR or similar procedures may
be used for this purpose. Predictions of disease recurrence ... FREE PSA RISK ASSESSMENT
The probability of prostate cancer for men with non-suspicious DRE results, by
age group, using PSA values between 4.000 and 10.000 ng/mL and percent FREE
https://www.justice.gov/epstein/files/DataSet%209/EFTA01100382.pdf
EFTA00599643Set 9
2016-01-285p1,558w
assay should not be the only test used for diagnostic purposes.
Additional evaluation using DRE, ultrasound, TUR or similar procedures may
be used for this purpose. Predictions of disease recurrence ... FREE PSA RISK ASSESSMENT
The probability of prostate cancer for men with non-suspicious DRE results, by
age group, using PSA values between 4.000 and 10.000 ng/mL and percent FREE
https://www.justice.gov/epstein/files/DataSet%209/EFTA00599643.pdf